Summary XCounter AB (XCounter) develops manufactures and markets high-performance X-Ray imaging systems for medical, dental and industrial customers. It develops digital 3D-imaging systems for medical and industrial applications based on its proprietary X-ray technologies. Its technologies include XTC Solid State Detector, XCT Gas Avalanche Detector, XCT-3T Tomosynthesis Engine and X-3T Tomosynthesis for breast imaging. The company also offers services for the designing, development and assembly of customized X-ray detectors. The company along with its subsidiary, Oy Ajat Ltd operates in Asia, Europe, North America and South America. XCounter's processes are ISO 9001: 2008 and ISO13485:2003 certified. XCounter is headquartered in Danderyd, Sweden. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company XCounter AB - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 XCounter AB Company Snapshot 6 XCounter AB Company Overview 6 XCounter AB Pipeline Products and Clinical Trials Overview 7 XCounter AB - Pipeline Analysis Overview 9 Business Description 9 Key Facts 10 XCounter AB - Major Products and Services 11 XCounter AB Pipeline Products by Development Stage 12 XCounter AB Pipeline Products Overview 14 High-Speed 3D Photon Counting Sensor 14 High-Speed 3D Photon Counting Sensor Product Overview 14 XC Cardio - 3T 15 XC Cardio - 3T Product Overview 15 XC Cardio - 4T 16 XC Cardio - 4T Product Overview 16 XC Mammo - 3T 17 XC Mammo - 3T Product Overview 17 XC MP-3T 18 XC MP-3T Product Overview 18 XC-DR450 - New Version 19 XC-DR450 - New Version Product Overview 19 XCounter AB - Key Competitors 20 XCounter AB - Key Employees 21 XCounter AB - Key Employee Biographies 22 XCounter AB - Locations And Subsidiaries 23 Head Office 23 Other Locations & Subsidiaries 23 Recent Developments 24 XCounter AB, Recent Developments 24 Jan 15, 2016: XCounter have appointed Lind as distributor for China 24 Nov 24, 2015: Latest Developments with XC-DR450 24 Nov 18, 2015: XCounter at JCHSIP2015 Japan 24 Nov 15, 2015: New Staff recruited in London Office 24 Apr 05, 2013: XCounter To Delist From NASDAQ OMX First North Stockholm 24 Dec 12, 2011: XCounter Appoints Fredrik Henckel As New CEO 24 Mar 31, 2011: XCounter Reports Revenue Of SEK34.8m In 2010 25 Sep 30, 2010: XCounter Reports Revenues Of SEK16.03 Million In H1 2010 25 Apr 22, 2010: XCounter Appoints Fredrik Henckel As New CFO 26 Mar 25, 2009: XCounter Posts Net Loss Of SEK112 Million In 2008 26 Appendix 28 Methodology 28 About GlobalData 28 Contact Us 28 Disclaimer 28
List of Tables
XCounter AB Pipeline Products and Clinical Trials Overview 7 XCounter AB Pipeline Products by Equipment Type 7 XCounter AB Pipeline Products by Indication 8 XCounter AB, Key Facts 10 XCounter AB, Major Products and Services 11 XCounter AB Number of Pipeline Products by Development Stage 12 XCounter AB Pipeline Products Summary by Development Stage 13 High-Speed 3D Photon Counting Sensor - Product Status 14 High-Speed 3D Photon Counting Sensor - Product Description 14 XC Cardio - 3T - Product Status 15 XC Cardio - 3T - Product Description 15 XC Cardio - 4T - Product Status 16 XC Cardio - 4T - Product Description 16 XC Mammo - 3T - Product Status 17 XC Mammo - 3T - Product Description 17 XC MP-3T - Product Status 18 XC MP-3T - Product Description 18 XC-DR450 - New Version - Product Status 19 XC-DR450 - New Version - Product Description 19 XCounter AB, Key Employees 21 XCounter AB, Key Employee Biographies 22 XCounter AB, Subsidiaries 23
List of Figures
XCounter AB Pipeline Products by Equipment Type 8 XCounter AB Pipeline Products by Development Stage 12
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expectedRead More...
Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehiRead More...
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.